Viking Therapeutics
VKTX
VKTX
164 hedge funds and large institutions have $454M invested in Viking Therapeutics in 2019 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 59 increasing their positions, 45 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
2.27% less ownership
Funds ownership: 65.79% → 63.51% (-2.3%)
2% less funds holding
Funds holding: 168 → 164 (-4)
13% less first-time investments, than exits
New positions opened: 26 | Existing positions closed: 30
Holders
164
Holding in Top 10
1
Calls
$29.3M
Puts
$18M
Top Buyers
| 1 | +$8.05M | |
| 2 | +$6.98M | |
| 3 | +$6.5M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$6.43M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.17M |
Top Sellers
| 1 | -$19.8M | |
| 2 | -$8.78M | |
| 3 | -$5.71M | |
| 4 |
PM
Prosight Management
Dallas,
Texas
|
-$4.77M |
| 5 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$3.38M |